Study to Evaluate the Safety and Tolerability of EP0042

Clinical trial NCT04581512 · RECRUITING

Trial details

NCT number: NCT04581512
Sponsor: Ellipses Pharma
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Acute Myeloid Leukemia Chronic Myelomonocytic Leukemia Myelodysplastic Syndromes

Start date: 2020-11-02
Primary completion: 2027-12-01
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.